Novo Nordisk's flagship weight-loss drug Wegovy has been approved for use in China, the Danish pharmaceutical giant said. The company — Europe's largest by market capitalization — confirmed to AFP on Tuesday that China had...
Semaglutide is no stranger to Li, who has previously used it in another drug to manage his blood sugar levels. Since Wegovy, a weight-loss drug with Semaglutide as its key ingredient, entered the Chinese market earlier this month, it has made headlines as a new tool for people like Li in...
Novo Nordisk could win approvals for expanded use of Wegovy in the U.S. and Europe. Eli Lilly's newly approved weight loss drug,Zepbound, could garner more than a billion dollars in sales in its first year on the market. Both companies are also expected to release new data that could ...
The drug semaglutide, the active ingredient in Ozempic and Wegovy, is already known to treat diabetes, aidrapid weight loss, and possibly evencurb drug and alcohol addictions. Now a new trial by the drug’s manufacturer, Novo Nordisk, has shown that it can collectively lower...
LONDON (Reuters) - Some Britons are set to be able to get Wegovy weight-loss injections after Novo Nordisk launched the drug in the UK on Monday, moving into its second major European market in just over a month despite struggling to meet soaring demand. ...
The weight-loss drug Wegovy has been cleared as a heart-disease preventative. How does it work? (Image credit: Noctiluxx via Getty Images) The drug semaglutide, sold commercially as Ozempic or Wegovy, is well known for helping people lose significant amounts of weight quickl...
"Wegovy is now the firstweight-loss medicationto also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight," said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obe...
"This is such a serious sort of potential complication that everybody who takes this drug should know about it," said Hobai, who was among the first to flag the issue. Nearly 6 million prescriptions for the class of drugs that include Wegovy and Ozempic were written between January and May...
Patients with obesity can now also takeZepbound, a rival weight-loss drug made by Eli Lilly. It was approved by the FDA in 2023 and contains a different active ingredient. When asked if Wegovy was designed to be taken for years or decades and whether it’s safe to be taken for the lo...
TUESDAY, June 24, 2024 (HealthDay News) -- Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women showed improved heart function after a year onsemaglutide, the active ingredient in Ozempic and Wegovy, research...